The global hematology market is anticipated to reach USD 53.8 billion by 2020 growing at a CAGR of 8.9% during the forecasting period, 2020-2028. Hematology is a disease that affects the production and function of blood cells. It has three types which are as follows leukemia, lymphoma, and myeloma. Factors such as rising incidences of blood disorders and technological advances in hematology are some of the major factors for the hematology market
The global hematology market is segmented into diagnosis, instruments price range, disorders, drugs, end-user, and geography.
Diagnosis segment is segmented into Instruments, Consumables, and Services
Instruments Price Range segment is segmented into High-End Hematology Analyzers, Mid-Range Hematology Analyzers, and Low-End Hematology Analyzers
Disorders segment is segmented into Anemia, Lymphoma, Leukemia, Multiple Myeloma, Myelodysplastic Syndrome and Others
Drugs segment is segmented into Andexxa (Coagulation Factor XA (Recombinant), Inactivated-ZHZO), Asparlas (Calaspargase PEGOL-MKNL), Copiktra (DUVELISIB), Daurismo (GLASDEGIB), Doptelet (Avatrombopag), Elzonris (Tagraxofusp-ERZS), JIVI (Antihemophilic Factor [Recombinant] Pegylated- AUCL), Keytruda (Pembrolizumab), Leukine (Sargramostim), Lokelma (Sodium Zirconium Cyclosilicate) and Others
End Users segment is segmented into Hospitals, Specialty Clinics, Diagnostic Laboratories, Academic Institutes, and Others
Geographically, the global hematology market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
North America region is the largest contributor to the hematology market in the forecast period 2020-2028 and the Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.
Key players in the global hematology market are Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA, Bio-Rad Laboratories, BioSystems, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Ortho Clinical Diagnostics, Roche among others
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
Hence, tremendous progress has been made over the last decade, and yet a lot more to come in recent years.
|
Report Features |
Description |
|---|---|
|
Market Revenue In 2020 |
USD 53.8 billion |
|
Growth Rate |
CAGR of 8.9% during the forecasting period, 2020-2028 |
|
Historical Data |
2017-2018 |
|
Forecast Years |
2020-2028 |
|
Base Year |
2019 |
|
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
|
Report Segmentation |
Diagnosis, Instruments Price Range, Disorders, Drugs, End-User, and Geography. |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Sysmex, Danaher, Nihon Kohden, Siemens, Abbott Laboratories, Boule Diagnostics, HORIBA, Bio-Rad Laboratories, BioSystems, Diatron, Drew Scientific, EKF Diagnostics, Mindray, Ortho Clinical Diagnostics, Roche among others |
|
Available Customization |
In addition to the market data for the hematology market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirements. |
.png)
.png)
.png)
.png)
.png)
.png)